American Journal of Medicine and Medical Sciences

p-ISSN: 2165-901X    e-ISSN: 2165-9036

2019;  9(1): 417-420

doi:10.5923/j.ajmms.20190911.02

 

Transaortic Myectomy without Intervention on the Mitral Valve

Kh. K. Abralov, M. M. Mirsaidov

Republican Specialized Scientific-Practical Medical Center of Surgery Named after Academician V.Vakhidov, Tashkent, Uzbekistan

Copyright © 2019 The Author(s). Published by Scientific & Academic Publishing.

This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/

Abstract

The article gives a retrospective analysis of 65 patients who have been performed a septal myectomy without intervention on the mitral valve for the last 17 years. The operated patients were divided into two groups subject to the degree of mitral insufficiency: the 1st group – 51 patients with mitral regurgitation up to degree I and the 2nd group – 14 patients with mitral regurgitation of degree II and higher. The mean age in the I and II groups was not significantly different and made up 19 ± 17 and 17.5 ± 9 years, respectively (p = 0.655). There were 29 (57%) women and 22 (43%) men in the first group, whereas in the second – 6 (43%) and 8 (57%) respectively (p = 0.631). Mortality was observed in 4 (6.2%) patients, the remaining 61 (93.8%) patients were in functional class I-II of NYHA. Trans-aortic myectomy gives good immediate results: systolic pressure gradient on the output path of the left ventricle and the degree of mitral regurgitation are significantly reduced despite the absence of interventions on the mitral valve.

Keywords: Hypertrophic obstructive cardiomyopathy, Myectomy, Mitral valve

Cite this paper: Kh. K. Abralov, M. M. Mirsaidov, Transaortic Myectomy without Intervention on the Mitral Valve, American Journal of Medicine and Medical Sciences, Vol. 9 No. 1, 2019, pp. 417-420. doi: 10.5923/j.ajmms.20190911.02.

1. Introduction

Hypertrophic obstructive cardiomyopathy (HOCMP) first described by Teare in 1958 is characterized by genetic disorders in cardiomyocytes and asymmetric left ventricular hypertrophy (LVH), the appearance of the pressure gradient on the level of the left ventricle output tract (LVOT) due to asymmetric hypertrophy of the interventricular septum (IVS) [1,5]. HCMP occurs in 0.2–0.5% of cases in the Europe and the USA (1 case per 500 people). It should be noted that 5% of this number are obstructive and have evident symptoms that are nonresponsive to drug therapy [3]. These patients need surgical treatment which gives long-term improvement in most of them [3]. Hypertrophic obstructive cardiomyopathy (HOCMP) remains the most common cause of sudden cardiac death (SCD) in young people including athletes. HCM accounts for up to 50% of sudden deaths among persons younger than 25 years. The mortality of patients in specialized centers dealing with this pathology is 3-6% per year [2].

2. Materials and Methods

We retrospectively analyzed 65 patients who underwent septal myectomy without interventions on the mitral valve from 2002 to 2019 at the Republican Specialized Scientific and Practical Medical Center of Surgery named after academician V. Vakhidov. The operated patients were divided into two groups depending on the degree of mitral insufficiency. 51 patients with mitral regurgitation up to degree I were included in the 1st group, the 2nd group – 14 patients with mitral regurgitation of degree II and higher. The mean age in the 1st and 2nd groups was not significantly different and made up 19 ± 17 and 17.5 ± 9 years, respectively (p = 0.655). There were 29 (57%) women and 22 (43%) men in the first group, whereas in the second – 6 (43%) and 8 (57%) respectively (p = 0.631). The rest of anthropometric characteristics are presented in Table 1.
Table 1. Clinical-demographic characteristics of patients
     
Preoperative and postoperative condition of patients were assessed according to the classification of the New-York Heart Association. The predominant functional class of NYHA group was formed by patients with grade II and accounted for 35 (69%) and 7 (50%) in groups I and II respectively (p = 0.114) (Tab.2).
Table 2. Comparative distribution of NYHA functional classes in the pre- and postoperative observation period in the studied patients
     
A study of patients with hypertrophic obstructive cardiomyopathy included general clinical and special research methods with the aim of making and confirming the diagnosis: history taking, examination, anthropometry, auscultation, X-ray, electrocardiography, transthoracic and transesophageal echocardiography. In diagnostically complex variants of hypertrophic obstructive cardiomyopathy, as well as to assess the severity of intracardiac hemodynamic disorders, angiocardiography with cardiac catheterization, as well as multislice spiral computed tomography (MSCT) were performed. Table 3 shows the distribution of the methods used according to the stages of the investigation.
Table 3. Distribution of methods according to the investigation stages
     
There was a large variation in values for age, weight and height of patients in the analyzed material. For the objectivity of the data echocardiographic indicators correlated to the body surface area (BSA) which made it possible to more reliably evaluate the indexed indicators of EchoCG. Indexed volume-linear indicators of echocardiography are presented in Table 4.
Table 4. Indexed Echocardiographic Indicators
     
In contrast to the classical tunnel-like technique proposed by Morrow, the myocardium of IVS was excised in the form of a trapezium and supplemented with radial incisions in the IVS (Fig.1). This technique has been patented in the Intellectual Property Agency of the Republic of Uzbekistan - Patent No. IAP 05074.
Figure 1. A. Aortotomy: the dotted line indicates the border of trapezoidal sector resection of IVS. B. Sector resection with trapezoidal gutter formation. C. Additional radial incisions along the circumference of the left ventricular outlet tract with a step of 3-5 mm, from the base of the heart to the apex beyond the formed gutter
The data analysis was performed using the STATISTICA for Windows Version 10.0 (Statsoft, Inc., USA) and Stata / SE for Windows Version 13.0 (StataCorp LP) programs. Quantitative signs are presented as arithmetic mean ± SD at a normal distribution, quantitative signs with a distribution different from normal are presented as a median and the corresponding interval between 25 and 75 percentiles (Q1; Q3). The following methods were used for statistical data processing:
1. Preliminary data processing, descriptive statistics;
2. Statistical hypothesis testing (Student's t-test and Fisher's F-test for testing hypotheses about the equality of the numerical characteristics of the sample data distributions);
3. Analysis of contingency tables (χ2 criterion);
4. Dispersion and regression analysis;
The significance level for all used methods was set as p≤0.05.

3. Results

The average patients stay in the intensive care unit (ICU) varied for the first group of patients from 1 to 8 days (average 1.0 ± 1.0) and in the second group from 1 to 3 days (average 1.5 ± 1.0) and did not differ significantly (p = 0.719). The duration of artificial lungs ventilation (ALV) varied from 160 to 3240 minutes and averaged 590 ± 580 in the first group and from 275 to 3745 minutes (average 532.5 ± 335) in the second group (p = 0.733). Statistical differences were not found when comparing groups for these parameters. Interventricular septum thickness was significantly reduced after surgery in both groups and averaged 2.76 ± 0.99 before surgery and 2.39 ± 0.78 after myectomy (p = 0.026). The systolic pressure gradient at the LVOT was reduced from 95.8 ± 36.3 to 29.6 ± 20.7 (p <0.001) in the first group and from 116.2 ± 43.5 to 42.3 ± 17, 2 (p = 0.002) in the second group respectivel. Iatrogenic defects of IVS after myectomy was not observed in any group. No injuries of the mitral valve or iatrogenic injury of the aortic valve was observed. The duration of cardiopulmonary bypass ranged from 18 to 125 (average 49.5 ± 29 min) in the first group and from 26 to 275 (average 50.5 ± 21min) in the second group (p = 0.826). The duration of cardioplegia varied from 11 to 74 (average 32 ± 23 min) in the first group and from 13 to 177 (average 24.5 ± 25 min) in the second (p = 0.376). 4 (7.8%) patients in the first group and 1 (7.1%) in the second group received permanent pacemakers postoperatively due to a complete AV block. One of these patients in the first group had a complete block of the right leg of the His bundle before the surgery. The appearance of a complete block of the left leg of His bundle is frequent during myectomy. Hemorrhage was noted in one patient from the first group after the surgery and therefore resternotomy and hemostasis were performed. Mediastinitis was developed in one more female patient in the postoperative period. In the dynamics after the treatment the wound was cleansed, secondary sutures were put on the wound. She was discharged in satisfactory condition. Acute heart failure requiring implantation of extracorporeal membrane oxygenation and transferring the patient to intensive care with mechanical support was noted in 1 patient of the 2nd group after the expansion of the aortic root. A fatal outcome was noted in the dynamics of this case. From 14 (28%) patients with mitral valve insufficiency of degree I only 7 (14%) had first-degree mitral insufficiency and in the rest of 7 (14%) patients after myectomy mitral insufficiency regressed postoperatively (p = 0.001). Similarly to the first group, from 14 patients with mitral insufficiency of degree II and III in the second group only 5 (41.6%) had mitral insufficiency II and 5 (41.6%) more cases regressed to mitral insufficiency of degree I (p = 0.461). We analyzed the degree of mitral insufficiency before and after surgery in both groups as a whole and a decrease in the degree of mitral insufficiency in both groups was confirmed with a high degree of confidence (p <0.001). Considering the significant difference in the thickness of the interventricular septum between the groups, we analyzed the correlation of mitral insufficiency degree with the thickness of the interventricular septum and revealed a moderate correlation r = 0.45 with reliability p <0.05.

4. Discussion

The presence of hemodynamically significant mitral insufficiency (MI) is one of the problems in patients with HOCMP. The development of MI is associated with a number of factors, the main of which is SAM - syndrome (accelerated movement of blood through the narrowed LVOT creates a low pressure zone, resulting in a turbulent flow that picks up the anterior cusp of mitral valve (MV) in the LVOT, which further intensifies the obstruction). An important factor in the development of MI is the anomaly of the chordopapillary apparatus of MV and papillary muscle (PM) hypertrophy. MV deficiency may also be associated with fibrotic changes of the anterior cusp due to prolonged mitral-septal contact at SAM syndrome. Concomitant mitral valve intervention is required in 11–20% of cases in patients undergoing myectomy [12]. In patients with evident lengthening of the anterior mitral valve and / or mitral regurgitation from moderate to severe degree, septal myectomy can be combined with one of several additional procedures, including replacement of the mitral valve, partial excision and mobilization of papillary muscles, plication of the anterior cusp and lengthening with a patch from the pericardium treated with glutaraldehyde, which strengthens the middle part of the anterior cusp of mitral valve [6-7,9-10]. At an elongated anterior cusp of mitral valve preference is given to plastic surgery instead of mitral valve replacement [4]. Surgical mortality in myectomy with intervention on the mitral valve is about 3-4% [8,10-11]. There have been a number of studies in which myectomy is performed without concomitant interventions on the mitral valve with a good result recently.

5. Conclusions

Trans-aortic myectomy gives good immediate results, and the gradient of systolic pressure in the left ventricular outflow tract and the degree of mitral regurgitation statistically significantly reduced, despite the absence of interventions on the mitral valve.

References

[1]  Bernard J. Gersh, Barry J. Maron, Robert O. Bonow, Joseph A. Dearani, Michael A. Fifer, Mark S. Link, Srihari S. Naidu, Rick A. Nishimura, Steve R. Ommen, Harry Rakowski, Christine E. Seidman, Jeffrey A. Towbin, James E. Udelson, Clyde W. Yancy, ACCF/AHA Task Force Members, Alice K. Jacobs, Sidney C. Smith, Jr., Jeffrey L. Anderson, Nancy M. Albert, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Harlan M. Krumholz, Frederick G. Kushner, Rick A. Nishimura, E. Magnus Ohman, Richard L. Page, William G. Stevenson, Lynn G. Tarkington and Clyde W. Yancy. A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. // J Thorac Cardiovasc Surg. 2011; 142: 153–203.
[2]  Elliott PM, Gimeno JR, Tomé MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. // Eur Heart J. 2006 Aug; 27(16): p. 1933-41.
[3]  Ferrazzi P, Spirito P, Iacovoni A, Calabrese A, Migliorati K, Simon C, Pentiricci S, Poggio D, Grillo M, Amigoni P, Iascone M, Mortara A, Maron BJ, Senni M, Bruzzi P. Transaortic Chordal Cutting. Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy. // J Am Coll Cardiol 2015. Vol. 66. P. 1687–96.
[4]  Kaple RK, Murphy RT, DiPaola LM, Houghtaling PL, Lever HM, Lytle BW, Blackstone EH, Smedira NG. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg 2008; 85:1527–1535.
[5]  Kirklin/Barratt-Boyes. Hypertrophic obstructive cardiomyopathy. In: Cardiac Surgery, 4nd edition. Philadelphia - Elsevier Saunders 2013: 769-791.
[6]  Kofflard MJ, van Herwerden LA, Waldstein DJ, Ruygrok P, Boersma E, Taams MA, Ten Cate FJ. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1996; 28: 197–202.
[7]  McIntosh CL, Maron BJ, Cannon RO III, Klues HG. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Circulation 1992; 86: II60–II67.
[8]  Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg 2004; 127: 481–489.
[9]  Reis RL, Bolton MR, King JF, Pugh DM, Dunn MI, Mason DT. Anterion-superior displacement of papillary muscles producing obstruction and mitral regurgitation in idiopathic hypertrophic subaortic stenosis. Operative relief by posterior-superior realignment of papillary muscles following ventricular septal myectomy. Circulation 1974; 50: II181–II188.
[10]  Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Longterm clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 1995; 92: II122–II127.
[11]  Stassano P, Di Tommaso L, Triggiani D, Contaldo A, Gagliardi C, Spampinato N. Mitral valve replacement and limited myectomy for hypertrophic obstructive cardiomyopathy: a 25-year follow-up. Tex Heart Inst J 2004; 31: 137–142.
[12]  Yu EH, Omran AS, Wigle ED, Williams WG, Siu SC, Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 2000; 36: 2219–2225.